SGLT-2 Inhibitors in Heart Failure: A Review of Current Evidence-Reference-Cited by-同舟云学术

SGLT-2 Inhibitors in Heart Failure: A Review of Current Evidence

Published:2023 Issue:2 Volume:5 Page:82
ISSN:2636-154X
Container-title:International Journal of Heart Failure
language:en
Short-container-title:Int J Heart Fail

Author:

Talha Khawaja M.¹^ORCID,Anker Stefan D.²^ORCID,Butler Javed¹³^ORCID

Affiliation:

1. Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.

2. Department of Cardiology (CVK), and Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Center for Cardiovascular Research (DZHK) Partner Site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.

3. Baylor Scott and White Research Institute, Dallas, TX, USA.

Funder

Abbott Vascular and Vifor International

Publisher

XMLink

Subject

General Medicine

Link

https://e-heartfailure.org/pdf/10.36628/ijhf.2022.0030

Reference47 articles.

1. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

2. T-1095, a renal Na+-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats

3. Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

4. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

5. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tackling the Disproportionate Burden of Resistant Hypertension in US Black Adults;Current Cardiology Reports;2024-09-05

2. Structures reveal how SGLT inhibitors work;Trends in Pharmacological Sciences;2024-09

3. Empagliflozin attenuates epithelial-to-mesenchymal transition through senescence in peritoneal dialysis;American Journal of Physiology-Renal Physiology;2024-09-01

4. Acidosis and aspiration: Popular diabetes medications and the risks they pose in the perioperative period;Journal of Clinical Anesthesia;2024-08

5. SGLT2 Inhibitor Use in Chronic Kidney Disease: Supporting Cardiovascular, Kidney, and Metabolic Health;Kidney Medicine;2024-08